Prolonged QT Interval and Torsades de Pointes Associated with Atazanavir Therapy
Author(s) -
Tran Duc Anh Ly,
Marı́a Elena Ruiz
Publication year - 2007
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/511875
Subject(s) - medicine , torsades de pointes , qt interval , atazanavir , cardiology , bradycardia , long qt syndrome , antiretroviral therapy , heart rate , human immunodeficiency virus (hiv) , virology , viral load , blood pressure
We report, to our knowledge, the first documented case of torsades de pointes associated with atazanavir therapy. This case serves to highlight the need to monitor patients receiving atazanavir therapy who have risk factors for QT interval prolongation, such as female sex, bradycardia, electrolyte abnormalities, congestive heart failure, and a baseline prolonged QT interval.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom